AS was influenced by angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARB), vitamin D in the pre-dialysis CKD patients [6,7], and by hypotensive medication combined with the reduction of calcium in the dialysis solution in hemodialysis patients [8]. This evidence concerns the gene ACE and chronic kidney disease.